OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8

Showing 8 citing articles:

The value of dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors: literature and practical aspects
A. Di Dia, Mahila Ferrari, Laura Lavinia Travaini, et al.
Clinical and Translational Imaging (2025)
Closed Access

Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET
Anas Aouf, Tilman Speicher, Arne Blickle, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

Gastroesophageal Neuroendocrine Tumors: Outcomes and Management
Christine Son, Joshua Kalapala, Jeff Leya, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2148-2148
Open Access

Gastrointestinal neuroendocrine tumor syndromes (GI-NETS)
Tetsuhide Ito, Robert T. Jensen
Elsevier eBooks (2025)
Closed Access

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy
B. Bogdanovič, Florent Hugonnet, Christopher Montemagno
Cancers (2025) Vol. 17, Iss. 7, pp. 1247-1247
Open Access

Development and Validation of a Novel Machine Learning Model to Predict the Survival of Patients with Gastrointestinal Neuroendocrine Neoplasms
Si Liu, Yunxiang Chen, Bing Dai, et al.
Neuroendocrinology (2024) Vol. 114, Iss. 8, pp. 733-748
Closed Access | Times Cited: 2

First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3)
Tilman Speicher, Caroline Burgard, Moritz B. Bastian, et al.
Clinical Nuclear Medicine (2024)
Closed Access

Page 1

Scroll to top